Angus D - Search Results

1

Clinical expert round table discussion (session 5) at the Margaux Conference on Critical Illness: outcomes of clinical trials in sepsis: lessons learned.

Vincent JL, Angus D, Annane D, Bernard G, Faist E, Giroir B, Reinhart K. Vincent JL, et al. Among authors: angus d. Crit Care Med. 2001 Jul;29(7 Suppl):S136-7. doi: 10.1097/00003246-200107001-00040. Crit Care Med. 2001. PMID: 11445749 No abstract available.

2

Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop.

Rubenfeld GD, Angus DC, Pinsky MR, Curtis JR, Connors AF Jr, Bernard GR. Rubenfeld GD, et al. Among authors: angus dc. Am J Respir Crit Care Med. 1999 Jul;160(1):358-67. doi: 10.1164/ajrccm.160.1.9807118. Am J Respir Crit Care Med. 1999. PMID: 10390426 No abstract available.

3

Epidemiology of sepsis: an update.

Angus DC, Wax RS. Angus DC, et al. Crit Care Med. 2001 Jul;29(7 Suppl):S109-16. doi: 10.1097/00003246-200107001-00035. Crit Care Med. 2001. PMID: 11445744 Review.

4

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.

Angus DC, Linde-Zwirble WT, Clermont G, Ball DE, Basson BR, Ely EW, Laterre PF, Vincent JL, Bernard G, van Hout B; PROWESS Investigators. Angus DC, et al. Crit Care Med. 2003 Jan;31(1):1-11. doi: 10.1097/00003246-200301000-00001. Crit Care Med. 2003. PMID: 12544986 Clinical Trial.

5

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis.

Ely EW, Laterre PF, Angus DC, Helterbrand JD, Levy H, Dhainaut JF, Vincent JL, Macias WL, Bernard GR; PROWESS Investigators. Ely EW, et al. Among authors: angus dc. Crit Care Med. 2003 Jan;31(1):12-9. doi: 10.1097/00003246-200301000-00002. Crit Care Med. 2003. PMID: 12544987 Clinical Trial.

6

Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial.

Vincent JL, Angus DC, Artigas A, Kalil A, Basson BR, Jamal HH, Johnson G 3rd, Bernard GR; Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Vincent JL, et al. Crit Care Med. 2003 Mar;31(3):834-40. doi: 10.1097/01.CCM.0000051515.56179.E1. Crit Care Med. 2003. PMID: 12626993 Clinical Trial.

7

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; International Sepsis Definitions Conference. Levy MM, et al. Among authors: angus d. Intensive Care Med. 2003 Apr;29(4):530-8. doi: 10.1007/s00134-003-1662-x. Epub 2003 Mar 28. Intensive Care Med. 2003. PMID: 12664219 Review.

8

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; SCCM/ESICM/ACCP/ATS/SIS. Levy MM, et al. Among authors: angus d. Crit Care Med. 2003 Apr;31(4):1250-6. doi: 10.1097/01.CCM.0000050454.01978.3B. Crit Care Med. 2003. PMID: 12682500 Review.

9

The PIRO concept: P is for predisposition.

Angus DC, Burgner D, Wunderink R, Mira JP, Gerlach H, Wiedermann CJ, Vincent JL. Angus DC, et al. Crit Care. 2003 Jun;7(3):248-51. doi: 10.1186/cc2193. Epub 2003 May 8. Crit Care. 2003. PMID: 12793879 Free PMC article. No abstract available.

10

Drotrecogin alfa (activated) treatment of older patients with severe sepsis.

Ely EW, Angus DC, Williams MD, Bates B, Qualy R, Bernard GR. Ely EW, et al. Among authors: angus dc. Clin Infect Dis. 2003 Jul 15;37(2):187-95. doi: 10.1086/375775. Epub 2003 Jul 8. Clin Infect Dis. 2003. PMID: 12856210 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

799 results

Search Page

Filters